These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8987385)

  • 1. Structure and function of the phosphotyrosine binding (PTB) domain.
    Zhou MM; Fesik SW
    Prog Biophys Mol Biol; 1995; 64(2-3):221-35. PubMed ID: 8987385
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor.
    Eck MJ; Dhe-Paganon S; Trüb T; Nolte RT; Shoelson SE
    Cell; 1996 May; 85(5):695-705. PubMed ID: 8646778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
    Rajala RV; Chan MD
    Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the NMR-derived motional parameters of the insulin receptor substrate 1 phosphotyrosine binding domain upon binding to an interleukin 4 receptor phosphopeptide.
    Olejniczak ET; Zhou MM; Fesik SW
    Biochemistry; 1997 Apr; 36(14):4118-24. PubMed ID: 9100005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of sulfotyrosine and phosphotyrosine by the Src homology 2 domain.
    Ju T; Niu W; Cerny R; Bollman J; Roy A; Guo J
    Mol Biosyst; 2013 Jul; 9(7):1829-32. PubMed ID: 23567872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
    Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
    Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTB or not PTB -- that is the question.
    Yan KS; Kuti M; Zhou MM
    FEBS Lett; 2002 Feb; 513(1):67-70. PubMed ID: 11911882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphotyrosine protein of molecular mass 30 kDa binds specifically to the positively charged region of the pleckstrin N-terminal pleckstrin homology domain.
    Liu L; Makowske M
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):423-30. PubMed ID: 10455030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR characterization of the near native and unfolded states of the PTB domain of Dok1: alternate conformations and residual clusters.
    Gupta S; Bhattacharjya S
    PLoS One; 2014; 9(2):e90557. PubMed ID: 24587391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1.
    Dhe-Paganon S; Ottinger EA; Nolte RT; Eck MJ; Shoelson SE
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8378-83. PubMed ID: 10411883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain.
    Zhou MM; Huang B; Olejniczak ET; Meadows RP; Shuker SB; Miyazaki M; Trüb T; Shoelson SE; Fesik SW
    Nat Struct Biol; 1996 Apr; 3(4):388-93. PubMed ID: 8599766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surprisingly flexible PTB domain.
    Siegal G
    Nat Struct Biol; 1999 Jan; 6(1):7-10. PubMed ID: 9886281
    [No Abstract]   [Full Text] [Related]  

  • 13. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains.
    Zhou Y; Abagyan R
    Fold Des; 1998; 3(6):513-22. PubMed ID: 9889165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
    Kristensen SM; Siegal G; Sankar A; Driscoll PC
    J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide library screening for determination of SH2 or phosphotyrosine-binding domain sequences.
    Songyang Z; Liu D
    Methods Enzymol; 2001; 332():183-95. PubMed ID: 11305095
    [No Abstract]   [Full Text] [Related]  

  • 16. PTB domain of insulin receptor substrate-1 binds inositol compounds.
    Takeuchi H; Matsuda M; Yamamoto T; Kanematsu T; Kikkawa U; Yagisawa H; Watanabe Y; Hirata M
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):211-8. PubMed ID: 9693122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH2 Domains as Affinity Reagents for Phosphotyrosine Protein Enrichment and Proteomic Analysis.
    Ke M; Chu B; Lin L; Tian R
    Methods Mol Biol; 2017; 1555():395-406. PubMed ID: 28092045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling of folding and binding in the PTB domain of the signaling protein Shc.
    Farooq A; Zeng L; Yan KS; Ravichandran KS; Zhou MM
    Structure; 2003 Aug; 11(8):905-13. PubMed ID: 12906822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
    Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
    van der Geer P; Wiley S; Pawson T
    Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.